Szamosvári D, Bae M, Bang S, et al. Lyme Disease, Borrelia burgdorferi, and Lipid Immunogens. J Am Chem Soc. 2022;144(6):2474-2478. doi:10.1021/jacs.1c12202.

Barczak AK, Avraham R, Singh S, et al. Systematic, multiparametric analysis of Mycobacterium tuberculosis intracellular infection offers insight into coordinated virulence. PLoS Pathog. 2017;13(5):e1006363. doi:10.1371/journal.ppat.1006363.

Xiong Y, Wiltsie J, Woods A, et al. The discovery of a potent and selective lethal factor inhibitor for adjunct therapy of anthrax infection. Bioorg Med Chem Lett. 2006;16(4):964-8. doi:10.1016/j.bmcl.2005.10.088.

Shoop WL, Xiong Y, Wiltsie J, et al. Anthrax lethal factor inhibition. Proc Natl Acad Sci U S A. 2005;102(22):7958-63. doi:10.1073/pnas.0502159102.

Jack S, Madhivanan K, Ramadesikan S, et al. A novel, safe, fast and efficient treatment for Her2-positive and negative bladder cancer utilizing an EGF-anthrax toxin chimera. Int J Cancer. 2020;146(2):449-460. doi:10.1002/ijc.32719.

Slater LH, Hett EC, Clatworthy AE, Mark KG, Hung DT. CCT chaperonin complex is required for efficient delivery of anthrax toxin into the cytosol of host cells. Proc Natl Acad Sci U S A. 2013;110(24):9932-7. doi:10.1073/pnas.1302257110.